Alphyn Biologics
Alphyn Biologics is a startup headquartered in Annapolis, United States, founded in 2019. It has raised at least $6.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Alphyn Biologics has raised at least $6.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Alphyn Biologics sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Annapolis
Related
Questions and answers
What does Alphyn Biologics do?
Alphyn Biologics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Alphyn Biologics raised?
At least $6.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Alphyn Biologics based?
Alphyn Biologics is headquartered in Annapolis, United States.
When was Alphyn Biologics founded?
Alphyn Biologics was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.